Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07218016 · ClinicalTrials.gov registry record · NA
The AccelERate Trial
A NA study of Pelvic Organ Prolapse and Pelvic Organ Prolapse (POP), sponsored by NICHD Pelvic Floor Disorders Network.
- Recruiting
- Registry status
- NA
- Development phase
- 288
- Enrollment target
- 7
- Study locations
NCT07218016: Recruiting NA study of Pelvic Organ Prolapse and Pelvic Organ Prolapse (POP), sponsored by NICHD Pelvic Floor Disorders Network.
NCT07218016 is a NA study of Pelvic Organ Prolapse and Pelvic Organ Prolapse (POP) that is actively recruiting participants, run by NICHD Pelvic Floor Disorders Network. The registered enrollment target is 288 participants, above the 138-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (109% higher). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07218016, a NA study of Pelvic Organ Prolapse and Pelvic Organ Prolapse (POP), is actively recruiting participants, sponsored by NICHD Pelvic Floor Disorders Network.
- RECRUITING
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
- 7
- Study locations
Study Summary
The AccelERate study will evaluate the physical recovery of patients who have undergone Pelvic Organ Prolapse (POP) surgery. This will be evaluated via a self-reported recovery questionnaire completed daily. Participants will wear an accelerometer device on their non-dominant wrist and be given either routine or exercise-focused postoperative instructions. The primary outcome will be a comparison of the number of days needed to reach self-reported "mostly recovered" status between randomly assigned instruction groups.
Primary Outcome
A participant will be considered "mostly recovered" if they report feeling "mostly" or "completely" recovered on 2 consecutive daily self-report occasions, allowing for skipped days. The primary outcome will be number of days since surgery at which the participant first reports feeling mostly recovered, provided they confirm that status on the next consecutive occasion.
Conditions Studied
Interventions
- BEHAVIORAL Postoperative Exercise regimen
Study Locations (7)
California
- Kaiser Permanente -- San Diego - San Diego
- University of California - San Diego - San Diego
Illinois
- University of Chicago - Chicago
North Carolina
- Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery - Durham
Pennsylvania
- University of Pennsylvania - Philadelphia
Rhode Island
- Brown/ Women and Infants Hospital of Rhode Island, Division of Urogynecology and Reconstructive Pelvic Surgery - Providence
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2025-10-02 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT07218016 shows while recruiting
NCT07218016 is an interventional study that assigns participants to a tested intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap, above the 138-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (109% higher).
The record links to 4 conditions, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 1 intervention - of which Postoperative Exercise regimen is the first listed.
NCT07218016 lists 7 locations in 6 states (California, Illinois, North Carolina).
Frequently Asked Questions
What is clinical trial NCT07218016 about?
NCT07218016 is a clinical study titled "The AccelERate Trial". The AccelERate study will evaluate the physical recovery of patients who have undergone Pelvic Organ Prolapse (POP) surgery. This will be evaluated via a self-reported recovery questionnaire completed daily. Participants will wear an accelerometer device on their non-dominant wrist and be given eith...
What is the current status of trial NCT07218016?
This trial is currently recruiting. It is a NA study. The enrollment target is 288 participants. The study started on 2025-10-02. Estimated completion is 2028-12-31.
What conditions does trial NCT07218016 study?
This clinical trial studies the following conditions: Pelvic Organ Prolapse, Pelvic Organ Prolapse (POP), Pelvic Organ Prolapse Vaginal Surgery, Pelvic Organ Prolapse, Patient Education.
What interventions are being tested in trial NCT07218016?
The interventions under investigation include: Postoperative Exercise regimen (BEHAVIORAL).
Who is sponsoring clinical trial NCT07218016?
This trial is sponsored by NICHD Pelvic Floor Disorders Network, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07218016 being conducted?
This trial has 7 study locations across California, Illinois, North Carolina, Pennsylvania, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Organ Prolapse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07218016's enrollment target sits among peer trials
288 4th of 40 higher than 37 of 40 other Pelvic Organ Prolapse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pelvic Organ Prolapse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SORE Study: Sitz Baths After Urogynecologic Reconstruction
RECRUITING · NA
-
POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
RECRUITING · NA
-
Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy
RECRUITING · NA
-
Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery
ACTIVE NOT RECRUITING · NA
-
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
ACTIVE NOT RECRUITING · NA
-
Clinical Investigation of the da Vinci Surgical System
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
- NCT03741777 · 288 participants · NA
Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume
- NCT03937635 · 288 participants · Phase 3
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- NCT04621877 · 288 participants · NA
Lay-Delivered Behavioral Activation in Senior Centers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI